Laura Basterretxea - Publications

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium.

Journal: Clinical genitourinary cancer

Published: January 15, 2026

Randomized non-comparative phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 02, 2026

Effects of a 12-week multicomponent exercise programme on physical function in older adults with cancer: Study protocol for the ONKO-FRAIL randomised controlled trial.

Journal: Journal of geriatric oncology

Published: September 03, 2025

Effects of a 12-week multicomponent exercise programme on physical function in older adults with cancer: Study protocol for the ONKO-FRAIL randomised controlled trial.

Journal: Journal of geriatric oncology

Published: September 03, 2025

Pilot phase 2 study of the efficacy, safety, and tolerability of first-line cabozantinib for older fragile patients with metastatic renal cell carcinoma: The SOGUG-CABOMAYOR study.

Journal: Journal of geriatric oncology

Published: February 14, 2025

Avelumab maintenance in advanced urothelial carcinoma: real-world data from Northern Spain (AVEBLADDER study).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 28, 2025

Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients.

Journal: International journal of molecular sciences

Published: May 20, 2024

Prediction of Chemotoxicity, Unplanned Hospitalizations and Early Death in Older Patients with Colorectal Cancer Treated with Chemotherapy.

Journal: Cancers

Published: December 12, 2021

Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists.

Journal: Frontiers in oncology

Published: September 09, 2021

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.

Journal: Nature communications

Published: March 26, 2021

Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for Cancer.

Journal: Journal of clinical medicine

Published: March 06, 2021

Prediction of Unplanned Hospitalizations in Older Patients Treated with Chemotherapy.

Journal: Cancers

Published: January 23, 2021